NAD+ IV vs oral precursors: what the delivery research shows
Two routes, two very different research pictures — here's how IV NAD+ and oral precursors actually compare.
TL;DR
IV NAD+ (nicotinamide adenine dinucleotide given through a vein) reaches the bloodstream immediately. Oral NMN and NR precursors take longer but have more published human trial data behind them. Neither route has established long-term health outcomes — only blood-level changes.
NAD+ IV vs oral NMN: what they are
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme — a helper molecule every cell needs to convert food into usable energy. Levels naturally decline with age. Two main paths exist to raise them. One is an IV (intravenous, delivered through a vein) infusion of NAD+ itself. The other is an oral precursor — a building-block compound the body converts into NAD+. The three most-studied precursors are NMN (nicotinamide mononucleotide), NR (nicotinamide riboside), and niacin (a B3 vitamin also called nicotinic acid).
How it works
Think of NAD+ like a delivery truck too large to fit through a cell's front door. IV delivery gets it into the bloodstream fast, but much of it breaks down before cells absorb it whole. NMN and NR act like smaller spare parts instead. Cells import them through dedicated transporters, then assemble them into NAD+ internally. That size difference is why researchers study precursors and direct infusion separately.
Who asks about it
People considering PRESERVE-track longevity support often ask which method "does more." Is it an IV drip at a clinic, or a daily oral capsule at home? The answer depends on what "more" means: faster blood-level change, or a lasting health benefit. Those are not the same question.
What the research says
A placebo-controlled trial in overweight adults tested oral NR at three doses. Whole blood NAD+ rose 142% at 1,000 mg and 22% at 100 mg, both within two weeks (Airhart, 2017). A separate randomized trial gave 80 healthy middle-aged adults oral NMN for 60 days. Doses of 300-900 mg daily raised blood NAD+, with 600 mg producing the strongest effect (GeroScience, 2022). Published IV NAD+ human trials remain smaller. Most track tolerability, not long-term outcomes.
What to know before considering it
Raising a blood NAD+ number is not the same as a confirmed clinical benefit. Much of the strongest "NAD+ helps with X" evidence comes from animal studies, which do not automatically apply to people. No published trial has directly compared IV NAD+ against oral NMN or NR for the same health outcome.
The Halftime POV
We treat delivery choice as an open research question, not a settled one. A physician evaluation should weigh cost, evidence quality, and individual goals — not marketing claims that one route is superior.
Related reading:
- NAD+: what it is
- How NAD+ works in the body
- NAD+ vs NMN vs NR
- NAD+ and peptides: how longevity practitioners combine protocols
FAQ
Is IV NAD+ better than oral NMN? IV NAD+ enters the bloodstream directly, skipping digestion. Oral NMN goes through the gut first. Both raise blood NAD+ in studies. No trial has directly compared the two for long-term outcomes, so "better" isn't settled by current data.
How is NAD+ best absorbed? NAD+ itself breaks down before cells use it whole, by either route. Smaller precursors like NMN and NR cross into cells more easily and get converted into NAD+ inside the body.
What raises NAD+ levels the most? In dose-ranging trials, 1,000 mg of oral NR raised whole blood NAD+ by 142% over two weeks (Airhart et al., 2017). Higher doses raised levels more, but bigger blood-level jumps haven't been shown to produce bigger health benefits.
Are NMN and NR the same thing? No. Both are vitamin B3-related precursors the body converts into NAD+. They use different cell entry routes and have separate human trial data.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Want to know when Halftime Health launches PRESERVE-track longevity support? Join the waitlist for updates.
Sources
- Airhart SE, et al. "An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers." PLOS ONE, 2017. PMC5718430.
- Conze D, et al. "Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride)." Scientific Reports, 2019. PMC6611812.
- Yi L, et al. "The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults." GeroScience, 2022.
Frequently asked questions
Is IV NAD+ better than oral NMN?
IV NAD+ (nicotinamide adenine dinucleotide given by intravenous infusion) puts the compound straight into the bloodstream, skipping digestion. Oral NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) go through the gut first. Both routes raise blood NAD+ in studies. No trial has directly compared IV to oral for long-term health outcomes, so 'better' is not yet answered by data.
How is NAD+ best absorbed?
NAD+ is a large molecule that breaks down before cells can use it whole, whether taken orally or by IV. Precursors like NMN and NR are smaller and cross into cells more easily, then get converted into NAD+ inside the body.
What raises NAD+ levels the most?
In dose-ranging trials, 1,000 mg of oral NR raised whole blood NAD+ by 142% over two weeks (Airhart et al., 2017). Higher doses raised levels more, but bigger blood-level jumps have not been shown to produce bigger health benefits.
Are NMN and NR the same thing?
No. Both are vitamin B3-related precursors (building blocks) the body converts into NAD+. They use different entry routes into cells and have been tested in separate human trials.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.